BACKGROUND. Phenylketonuria is a metabolic disorder that results from a deficiency of the hepatic enzyme phenylalanine hydroxylase. Its clinical phenotype varies widely, and to date more than 10 mutations in the phenylalanine hydroxylase gene have been identified in persons with the disorder. We attempted to relate the clinical phenotype of patients to their genotype. METHODS. We studied 258 patients with phenylketonuria from Denmark and Germany for the presence of eight mutations previously found in patients from these countries. The in vitro activity of the enzymes associated with these mutations was determined by expression analysis in heterologous mammalian cells. The level of activity was then used to predict the in vivo level of phenylalanine hydroxylase activity in patients with various combinations of mutant phenylalanine hydroxylase alleles. RESULTS. The eight mutations involved 64 percent of all mutant phenylalanine hydroxylase alleles in the patients. Expression analysis showed that these mutant enzymes produced from 0 to 50 percent of normal enzyme activity. The predicted level of phenylalanine hydroxylase activity correlated strongly with the pretreatment serum level of phenylalanine (r = 0.91, P less than 0.001 in the Danish patients and r = 0.74, P less than 0.001 in the German patients), phenylalanine tolerance in the Danish patients (r = 0.84, P less than 0.001), and the serum phenylalanine level measured after standardized oral protein loading in the German patients (r = 0.84, P less than 0.001). CONCLUSIONS. Our results strongly support the hypothesis that there is a molecular basis for phenotypic heterogeneity in phenylketonuria. The establishment of genotype will therefore aid in the prediction of biochemical and clinical phenotypes in patients with this disease.
Source Information
Howard Hughes Medical Institute, Department of Cell Biology, Baylor College of Medicine, Houston, TX 77030.
This article has been cited by other articles:
Yalaz, K., Vanli, L., Yilmaz, E., Tokatli, A., Anlar, B.
(2006). Phenylketonuria in Pediatric Neurology Practice: A Series of 146 Cases. J Child Neurol
21: 987-990
[Abstract]
Erlandsen, H., Patch, M. G., Gamez, A., Straub, M., Stevens, R. C.
(2003). Structural Studies on Phenylalanine Hydroxylase and Implications Toward Understanding and Treating Phenylketonuria. Pediatrics
112: 1557-1565
[Abstract][Full Text]
Muntau, A. C., Roschinger, W., Habich, M., Demmelmair, H., Hoffmann, B., Sommerhoff, C. P., Roscher, A. A.
(2002). Tetrahydrobiopterin as an Alternative Treatment for Mild Phenylketonuria. NEJM
347: 2122-2132
[Abstract][Full Text]
Greeves, L. G, Patterson, C. C, Carson, D. J, Thom, R., Wolfenden, M. C, Zschocke, J., Graham, C. A, Nevin, N. C, Trimble, E. R
(2000). Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia. Arch. Dis. Child.
82: 216-221
[Abstract][Full Text]
Bross, R., Ball, R. O., Clarke, J. T. R., Pencharz, P. B.
(2000). Tyrosine requirements in children with classical PKU determined by indicator amino acid oxidation. Am. J. Physiol. Endocrinol. Metab.
278: E195-E201
[Abstract][Full Text]
Kleppe, R., Uhlemann, K., Knappskog, P. M., Haavik, J.
(1999). Urea-induced Denaturation of Human Phenylalanine Hydroxylase. J. Biol. Chem.
274: 33251-33258
[Abstract][Full Text]
Güttler, F., Azen, C., Guldberg, P., Romstad, A., Hanley, W. B., Levy, H. L., Matalon, R., Rouse, B. M., Trefz, F., de la Cruz, F., Koch, R.
(1999). Relationship Among Genotype, Biochemical Phenotype, and Cognitive Performance in Females With Phenylalanine Hydroxylase Deficiency: Report From the Maternal Phenylketonuria Collaborative Study. Pediatrics
104: 258-262
[Abstract][Full Text]
Fusetti, F., Erlandsen, H., Flatmark, T., Stevens, R. C.
(1998). Structure of Tetrameric Human Phenylalanine Hydroxylase and Its Implications for Phenylketonuria. J. Biol. Chem.
273: 16962-16967
[Abstract][Full Text]
Reilly, A. A., Bellisario, R., Pass, K. A.
(1998). Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography. Clin. Chem.
44: 317-326
[Abstract][Full Text]
Powars, D., Hiti, A.
(1993). Sickle Cell Anemia: {beta}s Gene Cluster Haplotypes as Genetic Markers for Severe Disease Expression. Arch Pediatr Adolesc Med
147: 1197-1202
[Abstract]
Kan, Y. W.
(1992). Development of DNA Analysis for Human Diseases: Sickle Cell Anemia and Thalassemia as a Paradigm. JAMA
267: 1532-1536
Previous
